UPAYA PENINGKATAN PARTISIPASI MASYARAKAT DALAM PENGEMBANGAN UBI JALAR DI KECAMATAN CILIMUS KABUPATEN KUNINGAN SEBAGAI KSK AGROPOLITAN

Kecamatan Cilimus memiliki potensi agribisnis yang baik dari ubi jalar, hal ini didukung dengan keberadaan industri pengolahan ubi jalar di Kecamatan Cilimus yang berorientasikan kepada agropolitan ubi jalar. Program Agropolitan yaitu penanaman, pemanenan, pengolahan, pemasaran ubi jalar. Tetapi petani di Kecamatan Cilimus tidak memanfaatkan hasil dan tidak mengolah hasil produksinya. Permasalahan yang terjadi yaitu akibat kurangnya pengetahuan masyarakat seperti dalam pemanfaatan hasil dan pengolahan produksi yang dapat memberikan keuntungan untuk masyarakat. kurangnya partisipasi masyarakat dalam pengambangan Ubi jalar dan memanfaatkan ubi jalar yaitu berdasarkan temuan peneliti diketahui bahwa hasil produksi langsung dijual ke pengepul dan atau tengkulak, serta banyak petani yang belum ikut tergabung dalam kelompok tani. Penelitian ini dimaksudkan dengan merumuskan upaya peningkatan partisipasi masyarakat dalam Pengembangan Ubi Jalar sebagai KSK agropolitan. Dengan menggunakan metode deskriftif kualitatif berdasarkan teori syarat partisipasi, bentuk partisipasi, dan tingkat partisipasi. Petani di Kecamatan Cilimus kesempatan untuk berpartisipasi tidak merata karena sebagian petani belum mengetahui adanya program KSK Agropolitan ubi jalar, dan petani tidak beredia menjadi anggota ataupun ketua dalam kelompok tani. Masyarakat sudah mampu dan ada kemauan untuk berpartisipasi didasari oleh fator petani memahami manfaat dari ubi jalar. Petani pernah berpartisipasi dalam bentuk tenaga. Tingkat partisipasi masyarakat yaitu berada pada partisipasi mandiri, hal ini berarti petani dalam bertani ubi jalar tidak ada keterlibatan dari pihak lain. Untuk meningkatkan partisipasi, petani meningkatkan komunikasi dengan pemerintah, petani bergabung dengan kelompok tani agar memiliki sarana untuk mengikuti pelatihan dalam penanaman maupun pemanenan ubi jalar. Kata Kunci : Partisipasi Masyarakat, Agropolitan, Ubi Jala

KAJIAN MINUMAN HERBAL SARI BUAH BELIMBING (Averrhoa carambola L) YANG DISUBTITUSI EKSTRAK KULIT MANGGIS (Garcinia mangostana), EKSTRAK DAUN SIRSAK (Annona muricata L) DAN EKSTRAK SARANG SEMUT (Myrmecodia Pendans)

Herbal drink is a mixture of several compounds of plant components or materials of diverse functions or benefits but has a good and usually not at all times be consumed only consumed at a certain period. Drinks are derived from herbs usually called herbal drinks, herbal drinks is usually combined with some other ingredients mix to enrich content in it which usually consists of a mixture of two or more herbal ingredients derived from plants, animals, minerals, preparations sarian (galenic) . The purpose of this study is to obtain the best formulation that can enrich the content of herbal beverage products of star fruit juice and provide alternative herbal beverage products to consumers. The benefits of the research is to provide an alternative herbal beverage for people who come from mixing herbal ingredients (mangosteen rind, ant nests, and soursop leaf) with star fruit juice which has a rich nutrient content value, safe to consume The design of experiments used in this study was a randomized block design (RBD) with one factor (one way) repeated 3 times with 10 level where each level is a herbal formulation that is different. Based on organoleptic test (hedonic) on color, flavor, and aroma in the preliminary study, concluded that the f4 with 50% concentration of the herbal ingredients, star fruit juice 35%, and 15% honey is selected sample. Based on the results of a major study concluded that the levels of tannins, vitamin C, and oxalic acid levels significantly affect the characteristics of star fruit juice herbal drinks. Treatment is selected from the main study treatment herbal drinks ie f8 star fruit juice with star fruit juice concentration of 35%, 15% honey, 25% ant nest extract, extracts of soursop leaves 12.5%, and 12.5% mangosteen peel extract with high levels of 0.4785% tannins, vitamin C content 19.17% and 0.1757% oxalic acid content and antioxidant activity of 2.32%

An ISS Small-Gain Theorem for General Networks

We provide a generalized version of the nonlinear small-gain theorem for the case of more than two coupled input-to-state stable (ISS) systems. For this result the interconnection gains are described in a nonlinear gain matrix and the small-gain condition requires bounds on the image of this gain matrix. The condition may be interpreted as a nonlinear generalization of the requirement that the spectral radius of the gain matrix is less than one. We give some interpretations of the condition in special cases covering two subsystems, linear gains, linear systems and an associated artificial dynamical system.Comment: 26 pages, 3 figures, submitted to Mathematics of Control, Signals, and Systems (MCSS

Living on the edge: Biofilms developing in oscillating environmental conditions

For the first time, the densities and diversity of microorganisms developed on ocean gliders were investigated using flow cytometry and Illumina MiSeq sequencing of 16S and 18S rRNA genes. Ocean gliders are autonomous buoyancy-driven underwater vehicles, equipped with sensors continuously recording physical, chemical, and biological parameters. Microbial biofilms were investigated on unprotected parts of the glider and surfaces coated with base, biocidal and chitosan paints. Biofilms on the glider were exposed to periodical oscillations of salinity, oxygen, temperature, pressure, depth and light, due to periodic ascending and descending of the vehicle. Among the unprotected surfaces, the highest microbial abundance was observed on the bottom of the glider’s body, while the lowest density was recorded on the glider’s nose. Antifouling paints had the lowest densities of microorganisms. Multidimensional analysis showed that the microbial communities formed on unprotected parts of the glider were significantly different from those on biocidal paint and in seawater

Diagnosis of recent and relapsed cases of human brucellosis by PCR assay

BACKGROUND: Brucellosis affects human populations in many developing countries including the Middle East, and Latin America where it is still endemic. It has been prevalent in Jordan for years, where 7842 cases of human brucellosis were registered at the Ministry of Health during 10 year-period. This study was initiated by the recent increase in the number of human cases diagnosed in a rural area in the Northern Jordan to help assess the status of the disease in that area. For this purpose blood specimens from brucellosis suspected cases were tested by serology, culture and PCR. METHODS: Peripheral blood specimens from 50 healthy control subjects and 165 seropositive patients having compatible signs and symptoms that were clinically diagnosed to have brucellosis were tested by blood culture, and by PCR. The PCR assay used genus-specific primers from the conserved region of the 16S rRNA sequence, which showed high specificity for the Brucella spp. RESULTS: Diagnosis of Brucella was established by PCR in 120 cases (72.7%). All of them were seropositive and 20 were positive by culture. Forty-eight of 58 (82.8%) of the relapsed cases two months after completing the treatment with an increase in the previous serological titers were positive by PCR. The assay has 85.7% positive predicative value, 100% sensitivity and specificity since it correctly identified all cases that were positive by blood cultures, 95.8% by serology and none of the control group was positive. CONCLUSIONS: Results showed that PCR assay can be applied with serology for the diagnosis of brucellosis suspected cases and relapses regardless of the duration or type of the disease without relying on the blood cultures, especially in chronic cases

Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic

Introduction Childhood cancer is a leading cause of death. It is unclear whether the COVID-19 pandemic has impacted childhood cancer mortality. In this study, we aimed to establish all-cause mortality rates for childhood cancers during the COVID-19 pandemic and determine the factors associated with mortality. Methods Prospective cohort study in 109 institutions in 41 countries. Inclusion criteria: children <18 years who were newly diagnosed with or undergoing active treatment for acute lymphoblastic leukaemia, non-Hodgkin's lymphoma, Hodgkin lymphoma, retinoblastoma, Wilms tumour, glioma, osteosarcoma, Ewing sarcoma, rhabdomyosarcoma, medulloblastoma and neuroblastoma. Of 2327 cases, 2118 patients were included in the study. The primary outcome measure was all-cause mortality at 30 days, 90 days and 12 months. Results All-cause mortality was 3.4% (n=71/2084) at 30-day follow-up, 5.7% (n=113/1969) at 90-day follow-up and 13.0% (n=206/1581) at 12-month follow-up. The median time from diagnosis to multidisciplinary team (MDT) plan was longest in low-income countries (7 days, IQR 3-11). Multivariable analysis revealed several factors associated with 12-month mortality, including low-income (OR 6.99 (95% CI 2.49 to 19.68); p<0.001), lower middle income (OR 3.32 (95% CI 1.96 to 5.61); p<0.001) and upper middle income (OR 3.49 (95% CI 2.02 to 6.03); p<0.001) country status and chemotherapy (OR 0.55 (95% CI 0.36 to 0.86); p=0.008) and immunotherapy (OR 0.27 (95% CI 0.08 to 0.91); p=0.035) within 30 days from MDT plan. Multivariable analysis revealed laboratory-confirmed SARS-CoV-2 infection (OR 5.33 (95% CI 1.19 to 23.84); p=0.029) was associated with 30-day mortality. Conclusions Children with cancer are more likely to die within 30 days if infected with SARS-CoV-2. However, timely treatment reduced odds of death. This report provides crucial information to balance the benefits of providing anticancer therapy against the risks of SARS-CoV-2 infection in children with cancer